Cytosorbents (CTSO) Restructuring Costs (2024 - 2026)

Cytosorbents' Restructuring Costs history runs 3 years deep, the most recent figure standing at $6.6 million for Q1 2026.

• Quarterly Restructuring Costs fell 5.12% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$252000.0 (down 100.98% YoY) and the FY2025 annual result came in at $102000.0, down 99.61% from the prior year.
• Restructuring Costs was $6.6 million for Q1 2026 at Cytosorbents, up from -$20.8 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $7.1 million in Q2 2025 and bottomed at -$20.8 million in Q4 2025.
• A 3-year average of $3.6 million and a median of $6.6 million in 2026 frame the typical range for Restructuring Costs.
• Peak annual rise in Restructuring Costs reached 14.01% in 2025, while the deepest fall reached 421.32% in 2025.
• Cytosorbents' Restructuring Costs stood at $6.5 million in 2024, then plunged by 421.32% to -$20.8 million in 2025, then soared by 131.54% to $6.6 million in 2026.
• Business Quant data shows CTSO's Restructuring Costs at $6.6 million in Q1 2026, -$20.8 million in Q4 2025, and $6.9 million in Q3 2025.